Seoul — July 14, 2026. Published after the market close; prices are official closing values.
The 30-second version
- The KOSPI closed at 6,856.83, up 0.73%, after sliding toward the 6,500 level intraday and then recovering — a fragile bounce after Monday’s 8.95% collapse.
- Semiconductors did all the heavy lifting: Samsung Electronics rose 3.34% and SK hynix 3.69%. The semiconductor group was the only one of eight sector ETF proxies to advance.
- The KOSDAQ fell 1.92% to 783.98, a fresh low for the year, dragged down by large-cap biotech and battery names.
- Foreign investors and institutions bought today’s KOSPI dip (roughly KRW 0.95 trillion and KRW 3.22 trillion net, respectively); retail investors took profits, selling about KRW 4.14 trillion.
- The Bank of Korea’s rate decision lands Thursday, July 16 — two days away.
A bounce, but from a very deep hole
Context matters here. The KOSPI closed at 8,394.65 on June 29. Two brutal weeks later — including a 7.89% drop on July 2 and Monday’s 8.95% plunge — it finished today at 6,856.83, still roughly 18% below that late-June level. Today’s 0.73% gain is a rebound within a slide, not a reversal of it.
What makes the bounce notable is that it happened against a hostile overnight backdrop. In the prior US session, the Philadelphia Semiconductor Index (SOX) fell 4.78% and the Nasdaq lost 1.55%. Korean chipmakers rallied anyway, on the view — widely cited in local coverage — that Monday’s selloff had simply overshot. Samsung Electronics closed at KRW 263,000 and SK hynix at KRW 1,913,000, both up more than 3%, and both closes were cross-verified against the official exchange feed.
One overnight number that looks alarming but needs a label: the iShares MSCI South Korea ETF (EWY) dropped 8.45% in the previous US session. That is a proxy from a different session — it was largely catching up to Monday’s Seoul crash, not signaling anything about today.
Who bought the dip — and who sold it
Today’s KOSPI flows flipped hard from the day before. Foreign investors net bought about KRW 952.8 billion (roughly $0.6 billion at today’s rate of about 1,493 won per dollar) and institutions net bought about KRW 3.22 trillion (roughly $2.2 billion), while individual investors net sold about KRW 4.14 trillion (roughly $2.8 billion), locking in gains on shares bought during the decline. On the KOSDAQ, the pattern differed: foreigners sold about KRW 247.1 billion while institutions and individuals were modest net buyers.
Compare that with the previous session, July 13, when — across KOSPI and KOSDAQ combined — individuals net bought KRW 3.89 trillion while foreigners sold KRW 1.67 trillion and institutions sold KRW 2.23 trillion. In other words, the sides swapped in a single day: retail caught Monday’s falling knife, and today sold into the professional bid.
The bigger picture is still one of foreign withdrawal: cumulative foreign net selling over the past five sessions stands at KRW 4.43 trillion (about $3.0 billion) across both markets. Sidelined cash remains substantial — investor deposits at brokerages stood at KRW 105.6 trillion (about $70.7 billion) and margin loans, a gauge of retail leverage, at KRW 35.6 trillion (about $23.8 billion), both as of July 10.
Celltrion’s trial withdrawal, KT’s shareholder-return day
The day’s most consequential corporate filing came from Celltrion, which disclosed via the DART regulatory system that it has terminated the European phase 3 trial of CTP51 early and voluntarily withdrawn the trial plan. CTP51 is its biosimilar of Keytruda, the blockbuster cancer immunotherapy. Celltrion shares slipped 1.31%, and the news fed a broader biotech rout: the bio sector proxy fell 3.37%, and on the KOSDAQ, Alteogen tumbled 11.69%.
Telecom operator KT went the other way on the shareholder-return front, filing a cluster of decisions in one day: a treasury share buyback, a treasury share disposal, and a cash/in-kind dividend with its record date. Hanwha Engine also announced a buyback, and Hana Financial Group reported completion of one.
Elsewhere the tape was ugly outside chips. By sector ETF proxy (which can deviate slightly from official sector indices): securities firms fell 4.48%, autos 3.93% — Hyundai Motor lost 4.39% and Kia 2.72% — and secondary batteries 3.16%, with Samsung SDI down 2.84% and LG Energy Solution down 1.98%.
The macro backdrop: oil, a hawkish Fed, and the BOK on deck
Two external pressures framed the session. First, geopolitics: rising risk of a US-Iran military confrontation pushed WTI crude up 2.84% to $80.36, an unwelcome cost shock for an energy-importing economy like Korea. Second, monetary policy: hawkish comments from US Federal Reserve officials kept tightening fears alive. The won firmed slightly, with the dollar at 1,493.18 won on the global 24-hour feed (the official Seoul close may differ marginally). The VIX, at 17.22, remains surprisingly calm given the week Korea has had. All of this makes Thursday’s Bank of Korea rate decision the next genuine catalyst.
Key closing numbers
| Measure | Close (Jul 14, 2026) | Change |
|---|---|---|
| KOSPI | 6,856.83 | +0.73% |
| KOSDAQ | 783.98 | -1.92% |
| Samsung Electronics | KRW 263,000 | +3.34% |
| SK hynix | KRW 1,913,000 | +3.69% |
| Hyundai Motor | KRW 424,500 | -4.39% |
| USD/KRW (global feed) | 1,493.18 | -0.35% |
| WTI crude | $80.36 | +2.84% |
| VIX | 17.22 | +0.35% |
What to watch next
- Bank of Korea rate decision, Thursday, July 16. The single biggest scheduled event of the week, arriving with the market down sharply from late June.
- Foreign flows. Today’s KOSPI buying is one session against KRW 4.43 trillion of combined net selling over five days. Persistence is the test.
- US chip stocks. The SOX fell 4.78% in the prior session; whether Samsung and SK hynix can keep rallying against that current is an open question.
- Oil and the Middle East. WTI at $80.36 and climbing on US-Iran tension is a direct input into Korean inflation and the won.
- KOSDAQ stabilization. A year-low close and an 11.69% drop in Alteogen leave biotech sentiment fragile after the Celltrion trial withdrawal.
FAQ
Why did the KOSPI rise on July 14, 2026?
Dip-buying after Monday’s 8.95% crash, led by semiconductor heavyweights Samsung Electronics (+3.34%) and SK hynix (+3.69%). Foreign investors and institutions were net buyers of the KOSPI while retail investors took profits.
Why did the KOSDAQ hit a year low while the KOSPI rose?
The rebound was narrow — essentially a semiconductor story. Large-cap biotech and battery names on the KOSDAQ kept falling, with Alteogen down 11.69%, and foreign investors remained net sellers of that market.
What did Celltrion announce about its Keytruda biosimilar?
In a DART regulatory filing, Celltrion said it terminated the European phase 3 trial of CTP51, its Keytruda biosimilar, ahead of schedule and voluntarily withdrew the trial plan. The stock closed down 1.31%.
When is the next Bank of Korea rate decision?
Thursday, July 16, 2026 — two days after this session. With the KOSPI roughly 18% below its June 29 close, it is the week’s key domestic event.
Disclaimer: This is an information and analysis publication, not investment advice. See our Methodology for data sources, standards, and our corrections policy.